bench fermenter-jpg

The supply chain for artemisinin, the key drug in artemisinin combination therapies (ACTs), is complex and challenging.




30% of needed supply of artemisinin is produced semi-synthetically by Sanofi, while the remainder must come from A. annua plant extraction.




Will the crop supply enough material for global demand?




Zagaya is working to ensure affordable access of these life-saving drugs for all in need.


Register & Submit an Abstract: World Malaria Day 2014 Symposium





Registration is now open for the third annual Bay Area World Malaria Day Symposium! The Symposium will be held on Friday, April 25th at the Clark Kerr Campus in Berkeley. More information.

The Journey to Semi-synthetic Artemisinin


Everyone Cares

Human life has value, and no one wants others to die unnecessarily. Malaria has been eliminated in so much of our globe already (maps courtesy UCSF Global Health group), that we know global elimination is close. Make a difference in the fight against malaria; collaborate, partner and share our knowledge for a malaria-free world! Learn more

Copyright © 2014 zagaya | Admin
zagaya is a non-profit, 501 (c) (3) public benefit corporation. Our Federal EIN number is: 35-2411548